These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 2957541

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Aquaretic drugs--a new therapeutic principle in treatment of hyponatremia?].
    Hensen J, Buchfelder M, Gross P.
    Fortschr Med; 1997 Jun 20; 115(17):46-50. PubMed ID: 9312543
    [Abstract] [Full Text] [Related]

  • 4. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M, Stoev S, Chini B, Durroux T, Mouillac B, Guillon G.
    Prog Brain Res; 2008 Jun 20; 170():473-512. PubMed ID: 18655903
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
    Palm C, Pistrosch F, Herbrig K, Gross P.
    Am J Med; 2006 Jul 20; 119(7 Suppl 1):S87-92. PubMed ID: 16843091
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hyponatremia of cirrhosis: role of vasopressin and decreased 'effective' plasma volume.
    Akriviadis EA, Ervin MG, Cominelli F, Fisher DA, Reynolds TB.
    Scand J Gastroenterol; 1997 Aug 20; 32(8):829-34. PubMed ID: 9282977
    [Abstract] [Full Text] [Related]

  • 11. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
    Wong F, Blei AT, Blendis LM, Thuluvath PJ.
    Hepatology; 2003 Jan 20; 37(1):182-91. PubMed ID: 12500203
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of arginine vasopressin receptor antagonists in hyponatremia in the elderly.
    Miller M.
    Geriatrics; 2007 Jul 20; 62(7):20-6. PubMed ID: 17620018
    [Abstract] [Full Text] [Related]

  • 16. Vasopressin receptor antagonists: potential indications and clinical results.
    Arai Y, Fujimori A, Sudoh K, Sasamata M.
    Curr Opin Pharmacol; 2007 Apr 20; 7(2):124-9. PubMed ID: 17292670
    [Abstract] [Full Text] [Related]

  • 17. Hyponatremia treatment guidelines 2007: expert panel recommendations.
    Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH.
    Am J Med; 2007 Nov 20; 120(11 Suppl 1):S1-21. PubMed ID: 17981159
    [Abstract] [Full Text] [Related]

  • 18. Hemodynamic response to vasopressin in dehydrated human subjects.
    Huch KM, Wall BM, Mangold TA, Bobal MA, Cooke CR.
    J Investig Med; 1998 Aug 20; 46(6):312-8. PubMed ID: 9737094
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Current concepts of volume receptor regulation of vasopressin release.
    Menninger RP.
    Fed Proc; 1985 Jan 20; 44(1 Pt 1):55-8. PubMed ID: 2981733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.